Ilika PLC reported that during the second half of 2025 it successfully completed a series of production and delivery milestones for its miniature Stereax solid-state batteries. The company manufactured over 50,000 individual cells across multiple production runs and fulfilled its first batch deliveries to three separate customers in the medical and industrial sectors. On the strength of these achievements, Ilika now anticipates receiving follow-on orders for Stereax batteries before the end of the current year, underpinned by letters of intent representing cumulative demand of more than 200,000 units.

In parallel with its Stereax progress, Ilika has accelerated development of its larger-format Goliath solid-state battery, targeting electric vehicle and appliance markets. In January 2026 the group shipped a new 10 amp-hour Goliath prototype to two major automotive OEMs and one global appliance manufacturer for evaluation. This delivery follows internal test results showing an energy density exceeding 300 Wh/kg and cycle life above 1,000 charging cycles under accelerated conditions, bringing the technology within striking distance of commercial readiness.

Ilika confirmed receipt of its first commercial order from US partner Cirtec Medical for the supply of electrodes, the key conductive component in its miniature Stereax batteries. This contract follows two years of joint development effort and marks the transition into ongoing commercial production. The announcement spurred a 2% increase in Ilika’s share price on the AIM market, building on a 77% total share gain over the past 12 months as investors respond to the company’s clear path to recurring revenue streams.